Aclaris Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.7M | 1.4M | 1.90 |
| 2025-06-30 | $1.6M | 1.1M | 1.42 |
| 2025-03-31 | $1.8M | 1.2M | 1.53 |
| 2024-12-31 | $270k | 109k | 2.48 |
| 2024-09-30 | $424k | 369k | 1.15 |
| 2024-06-30 | $981k | 892k | 1.10 |
| 2024-03-31 | $1.2M | 983k | 1.24 |
| 2023-12-31 | $5.7M | 5.4M | 1.05 |
| 2023-09-30 | $25M | 3.7M | 6.85 |
| 2023-06-30 | $29M | 2.8M | 10.37 |
| 2023-03-31 | $27M | 3.4M | 8.09 |
| 2022-12-31 | $17M | 1.1M | 15.75 |
| 2022-06-30 | $13M | 953k | 13.96 |
| 2022-03-31 | $17M | 972k | 17.24 |
| 2021-12-31 | $15M | 1.0M | 14.54 |
| 2021-09-30 | $20M | 1.1M | 18.00 |
| 2021-06-30 | $23M | 1.3M | 17.57 |
| 2021-03-31 | $36M | 1.4M | 25.20 |
| 2020-12-31 | $805k | 124k | 6.47 |
| 2020-09-30 | $102k | 39k | 2.59 |
| 2020-03-31 | $38k | 51k | 0.75 |
| 2019-12-31 | $60k | 27k | 2.24 |
| 2019-09-30 | $56k | 75k | 0.75 |
| 2019-06-30 | $73k | 33k | 2.24 |
| 2019-03-31 | $1.1M | 189k | 5.98 |
| 2018-12-31 | $4.1M | 554k | 7.39 |
| 2018-09-30 | $13M | 882k | 14.52 |
| 2018-06-30 | $17M | 868k | 19.97 |
| 2018-03-31 | $16M | 897k | 17.51 |
| 2017-12-31 | $3.7M | 148k | 24.66 |
| 2017-09-30 | $6.2M | 242k | 25.81 |
| 2017-06-30 | $911k | 34k | 27.13 |
| 2017-03-31 | $1.5M | 51k | 29.82 |
| 2016-09-30 | $238k | 9.3k | 25.58 |